Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Powerful Enzymes Create Ethanol from Agricultural Harvest Waste

Published: Wednesday, January 09, 2013
Last Updated: Wednesday, January 09, 2013
Bookmark and Share
The mainly EU-funded DISCO project coordinated by VTT Technical Research Centre of Finland has developed powerful enzymes, which accelerate plant biomass conversion into sugars and further into products such as bioethanol.

The project's results include lignin-tolerant enzymes and enzyme cocktails for processing spruce, straw, corn cob and wheat bran. The commercialisation of these enzymes has now begun in the Netherlands.

The EU's DISCO project developed powerful enzymes and enzyme cocktails suitable for various raw materials, with the purpose of converting agricultural side streams into fermentable sugars and further into products such as bioethanol. Plant biomass was chosen as the raw material for the project, since it contains lignocellulosic biomass, which is an abundant raw material.

The commercialisation process of the second-generation bioethanol industry, which uses lignocellulosic biomass instead of starch, has reached critical momentum: there are a total of 15 plants being constructed in Europe, the Americas and Asia. Lignocellulosic biomass use will substantially expand the market for industrial enzymes. The total industrial enzyme market is currently worth approximately 2.7 million euros per annum.

The raw materials studied in the project were spruce, straw, corn cob and wheat bran used as animal feed. In Finland, the proportion of forest biomass, and conifer biomass in particular, is significant.
Lignocellulosic biomass consists of cellulose, hemicellulose and lignin. Agricultural harvest waste contains large amounts of lignocellulosic biomass, which can be converted industrially into fermentable sugars with the help of enzymes. Microbes can then be used to produce various chemicals, such as bioethanol, from the sugars. Lignocellulosic biomass contains substantial amounts of lignin, which interferes with enzyme activity.

The DISCO project produced new knowledge on the inactivating property of lignin, which helped scientists develop enzymes that tolerate lignin better. New information on enzymes and activities that break down hemicellulose, vital for the efficient exploitation of plant biomass, was also obtained during the project.

British scientists participating in the project determined the structural characteristics of various raw materials. This information can be used to select appropriate enzyme cocktails for raw materials when upgrading plant biomass.

The Dutch company Dyadic is currently commercialising the enzymes developed in the project.

Research Professor Kristiina Kruus of VTT coordinated the DISCO project, which had a total of 11 participants from seven countries. VTT's scientific role in the project related to discovering and developing enzymes from environmental samples as well as culture collections.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

VTT Printed a Morphine Test on Paper
Company use antibodies as morphine sensing molecules when creating this morphine test.
Saturday, April 18, 2015
European Research Project Aims at Early Diagnosis of Memory Disorders
800 patients to participate in testing new diagnostic procedures.
Thursday, March 20, 2014
Novel Cancer Cell DNA Damage Repair Mechanism
Findings result from application of the cell microarray screening method developed at VTT.
Monday, December 23, 2013
International Prize for VTT's Allergy Vaccine Development Work
First vaccines to be ready for launch in about five years.
Monday, December 09, 2013
Method Developed by VTT Targets Diagnosis of Early Alzheimer’s Disease
Half of patients could be diagnosed a year earlier than current clinical practice.
Friday, December 07, 2012
Food Industry’s High-Quality Co-Streams Used Effectively as Raw Material for New Products
Researchers develop new ways of using substantial co-streams from fish and oil plant processing.
Tuesday, August 14, 2012
VTT and GE Healthcare Developing Novel Biomarkers to Predict Alzheimer’s Disease
VTT and University of Eastern Finland scientists have discovered a serum biochemical signature.
Wednesday, June 27, 2012
Heparin-like Compounds Inhibit Breast Cancer Metastasis to Bone
Heparin-like compounds decreased bone destruction and tumor growth in bone.
Friday, June 15, 2012
VTT Identified Specific Bacteria which Precede Autoimmune Diabetes
New potential avenues for early disease detection and prevention.
Friday, October 28, 2011
Finnish Twin Study Yields New Information on How Fat Cells Cope With Obesity
The team used lipidomics to study the fat tissue biopsies among several sets of monozygotic twins.
Friday, July 29, 2011
One Step Closer to a Diagnostic Test for Schizophrenia
Scientists in Finland have revealed metabolic abnormalities that are associated with schizophrenia.
Thursday, April 14, 2011
VTT is Searching for New Drug Targets for Prostate Cancer in the New IMI PREDECT Project
PREDECT, one of IMI’s new projects, is developing novel models for breast, prostate and lung cancers.
Monday, April 04, 2011
New Potential Drug Targets Discovered for Preventing Prostate Cancer Cell Growth
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth.
Friday, February 18, 2011
Zora Biosciences Commercializes VTT's Biotechnology Expertise
Zora will provide laboratory services to pharmaceutical industry in the area of metabolomics and associated bioinformatics.
Wednesday, June 27, 2007
VTT Develops Software Tool to Integrate and Analyze Complex Medical Data
The megNet® software can be applied in understanding complex relations in living organisms, and characterizing various diseases, such as cardiac diseases and diabetes.
Friday, April 27, 2007
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!